Nav: Home

Almost 400 medical practices found ineffective in analysis of 3,000 studies

June 11, 2019

Scientists have identified nearly 400 established medical practices that have been found to be ineffective by clinical studies published across three top medical journals.

Writing in the open-access journal eLife, the team hope their findings will encourage the de-adoption of these practices, also known as medical reversals, ultimately making patient care more efficient and cost effective.

Medical reversals are practices that have been found to be no better than prior or lesser standards of care, through randomised controlled trials (RCTs: studies that aim to reduce certain types of bias when testing new treatments). But it can be difficult to identify these practices. For example, Cochrane Reviews provide high-quality evidence on medical practices, but only one practice is covered in each review and many have not been reviewed in this way. Additionally, the Choosing Wisely initiative in the US aims to maintain a list of low-value medical practices, but it relies on medical organisations to report them.

"We wanted to build on these and other efforts to provide a larger and more comprehensive list for clinicians and researchers to guide practice as they care for patients more effectively and economically," says lead author Diana Herrera-Perez, Research Assistant at the Knight Cancer Institute at Oregon Health & Science University (OHSU), US.

To do this, Herrera-Perez and her team conducted a search of RCTs published over 15 years in three leading general medical journals: the Journal of the American Medical Association, the Lancet and the New England Journal of Medicine.

Their analysis revealed 396 medical reversals from 3,000 articles. Of these, most were conducted on people in high-income countries (92%), likely because the majority of randomised trials are performed in this setting. Meanwhile, 8% were done in low or middle-income countries, including China, India, Malaysia and Ethiopia.

Cardiovascular disease was the most commonly represented medical category among the reversals (20%), followed by public health/preventive medicine (12%) and critical care (11%). In terms of the type of intervention, medication was the most common (33%), followed by a procedure (20%) and vitamins and/or supplements (13%).

"There are a number of lessons that we can take away from our set of results, including the importance of conducting RCTs for both novel and established practices," explains senior author Vinay Prasad, Associate Professor at the OHSU Knight Cancer Institute. "Once an ineffective practice is established, it may be difficult to convince practitioners to abandon its use. By aiming to test novel treatments rigorously before they become widespread, we can reduce the number of reversals in practice and prevent unnecessary harm to patients.

"We hope our broad results may serve as a starting point for researchers, policy makers and payers who wish to have a list of practices that likely offer no net benefit to use in future work."

Prasad adds that some limitations need to be taken into account with the results, including the fact that only three general medical journals were studied. This means the findings may not be broadly generalisable to all journals or fields. Additionally, other researchers may categorise results differently, depending on their expertise. To help overcome this issue, the team invited physicians from a range of backgrounds to review and comment on the practices identified as reversals.

"Taken together, we hope our findings will help push medical professionals to evaluate their own practices critically and demand high-quality research before adopting a new practice in future, especially for those that are more expensive and/or aggressive than the current standard of care," concludes co-lead author Alyson Haslam, PhD, also at the OHSU Knight Cancer Institute.
-end-
References

The paper 'A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals' can be freely accessed online at https://doi.org/10.7554/eLife.45183.

This work has been published as part of eLife's Meta-Research Collection, the full contents of which can be freely accessed online at https://elifesciences.org/collections/8d233d47/meta-research-a-collection-of-articles.

Contents, including text, figures and data, are free to reuse under a CC BY 4.0 license.

Media contact

Emily Packer, Senior Press Officer eLife
e.packer@elifesciences.org
01223 855373

About eLife

eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours in science. We publish important research in all areas of the life and biomedical sciences, including Epidemiology and Global Health, which is selected and evaluated by working scientists and made freely available online without delay. eLife also invests in innovation through open-source tool development to accelerate research communication and discovery. Our work is guided by the communities we serve. eLife is supported by the Howard Hughes Medical Institute, the Max Planck Society, the Wellcome Trust and the Knut and Alice Wallenberg Foundation. Learn more at https://elifesciences.org/about.

To read the latest Epidemiology and Global Health research published in eLife, visit https://elifesciences.org/subjects/epidemiology-global-health.

eLife

Related Hope Articles:

Hope is a key factor in recovering from anxiety disorders
A University of Houston psychologist is reporting that hope increases in therapy and is a trait that predicts resilience and recovery from anxiety disorders, an important mechanism for therapists to restore in patients to move them forward toward recovery.
New hope for treating childhood brain cancer
Recent research has shown that a drug known as MI-2 can kill cells that cause a fatal brain cancer.
Defending against cyberattacks by giving attackers 'false hope'
'The quarantine is a decoy that behaves very similar to the real compromised target to keep the attacker assuming that the attack is still succeeding.
'Cellular dust' provides new hope for regenerative medicine
While stem cells have the most therapeutic potential, the benefits of regenerative medicine may best be mobilised using extracellular vesicles (EVs), also known in the past as 'cellular dust'.
New hope from the 'seven year switch' in Type 1 diabetes
A team at the University of Exeter Medical School found evidence that the amount of insulin produced declines by almost 50 percent each year for seven years.
Growth hormone may provide new hope for stroke survivors
Less fatigue and better recovery of cognitive abilities such as learning and memory.
The case for hope: Educating as if survival matters
The world is facing ever-more-dire warnings from scientists about the faltering health of the environment and the negative consequences for humans, habitats, and the creatures with whom we share the Earth.
Hope for new treatment of severe epilepsy
Researchers at Lund University in Sweden believe they have found a method that in the future could help people suffering from epilepsy so severe that all current treatment is ineffective.
New study shows hope for hearing loss
USC and Harvard scientists found a new way to fix cells deep inside the ear, which could help millions of people who suffer hearing loss.
New antifungal provides hope in fight against superbugs
Microscopic yeast have been wreaking havoc in hospitals around the world -- creeping into catheters, ventilator tubes, and IV lines -- and causing deadly invasive infection.
More Hope News and Hope Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.